Compare McKesson Corporation (MCK) vs Occidental Petroleum Corporation (OXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Occidental Petroleum Corporation — how do they compare? McKesson Corporation trades at $829.3 (market cap $97.35B), while Occidental Petroleum Corporation trades at $55.88 (market cap $54.89B). The key difference: McKesson Corporation is the larger of the two by market cap, and Occidental Petroleum Corporation pays the higher dividend (1.88%). Which is the better fit depends on your goals.
| MCK | OXY | |
|---|---|---|
Market Cap | $97.35B | $54.89B |
Sector | Health | Energy |
52-Week High | $995.69 | $66.24 |
52-Week Low | $659.01 | $38.92 |
Enterprise Value | $101.98B | $75.98B |
Dividend Yield | 0.39% | 1.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
Occidental Petroleum (OXY) trades at $55.36, up 0.91% with a bullish technical signal. The company shows strong profitability with 22.42% net income margin and has beaten earnings estimates for three consecutive quarters. Recent news highlights capital spending reductions and Permian Basin growth potential. Analyst consensus is positive with a $65.38 price target representing 18% upside potential from current levels.
OXY presents a compelling investment case with improving debt metrics and consistent earnings outperformance. However, declining revenue trends from $36.6B in 2022 to $21.6B in 2025 and oil price sensitivity remain key risks. The stock's premium valuation (P/E 74.14) requires sustained execution to justify current levels amid volatile energy markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Occidental Petroleum Corporation
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →
